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I. STATE OF THE ART 
Lung cancer is the most common cancer in the world with about 1.3 million new 
cases diagnosed every year (1,2). 
Lung cancer mortality is among the highest, with a male/female ratio that is 4:3 
nowadays (1,2) . 
It is generally  agreed that surgery  is the best treatment option for lung cancer as 
it offers the only real potential for cure. Despite that, the survival rate after 
surgical therapy  is extremely  low (60 to 30% dependently by the stage of 
disease) (3,4). 
Moreover the surgical treatment exposes lung cancer patients to the risk of a 
postoperative deterioration of their functional status and quality of life (5). 
The traditional surgical option offered to cure patients with lung neoplasm is 
represented by an anatomic lung resection (lobectomy/ bilobectomy/ 
pneumonectomy) performed through a thoracotomic incision. 
During the last two decades, the literature has proposed evidence supporting 
alternative minimally invasive technique to perform major anatomic pulmonary 
resection. In particular, the video-assisted thoracic surgery (VATS) lobectomy 
seems to represent a valuable approach for selected patients as treatment of 
early-stage lung cancer. In fact, this technique reduces the hospital stay, allows a 
more rapid postoperative recovery with less pain and, above all, could offer a 
more favorable oncologic result as compared with the traditional thoracotomy 
approach (6). 
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Nevertheless scanty information is available about the impact of VATS lobectomy 
on the physical and mental status of lung cancer patients. So it appears crucial 
verifying the relapses of such an innovative technique on the actual 
postoperative pulmonary function tests (PFTs), lung diffusion capacity (DLCO), 
cardiorespiratory reserve, and quality of life of patients submitted to lung 
resection for cancer. 
I.1 Role of VATS lobectomy 
In 2007 the American College of Chest Physicians evidence-based clinical 
practice guidelines for Diagnosis and Management of Lung Cancer recommend 
that ‘‘In patients with stage I NSCLC who are considered appropriate candidates 
for thoracoscopic anatomic lung resection (lobectomy or segmentectomy), the 
use of VATS by surgeons experienced in these techniques is an acceptable 
alternative to open thoracotomy’’ (6). 
This statement is a consequence of the growing evidence that, in the last 15 
years, showed not only comparable but also better results of VATS lobectomy vs 
the standard open technique in terms of short- and long-term outcomes. 
In particular, operative mortality after VATS lobectomy ranges from 0% to 2.7%, 
which is comparable to the reported mean modern mortality for open lung cancer 
surgery (7) . Moreover the VATS lobectomy is associated with an acceptable 
morbidity  rate. Similarly to the open lobectomies, arrhythmias, prolonged air leak, 
and pneumonia are the most common complications (8). 
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On the other hand, the minimally  invasive approach seems to represent an 
advantage for some early outcomes of primary importance after thoracic surgery, 
such as the chest tube duration, the length of stay and the postoperative pain 
(7,9). 
Although in the past the long-term results initially reported limited the use of the 
thoracoscopic lobectomy, more recent papers reviewed the role of minimally 
invasive approach even from this point of view. Different studies demonstrated 
the advantages of the VATS lobectomy in terms of immunologic impact, 
compliance to adjuvant therapies and consequently of long-term oncologic 
results (10,11). 
I.2 Role of pulmonary function test and lung diffusion capacity 
Recently, two task forces, one represented by  the European Respiratory  Society 
(ERS) and the European Society of Thoracic Surgeons (ESTS) and the other by 
the British Thoracic Society (BTS) and the Society for Cardiothoracic Surgeons of 
Great Britain and Ireland (SCTS), published different guidelines about 
preoperative functional evaluation of patients undergoing lung resection (12,13).
As stated in both the ERS/ESTS and BTS/SCTS algorithms, the physic 
assessment of lung resection candidates should begin with the evaluation of lung 
function, by  the systematic measurement of forced expiratory volume in the 1st 
second (FEV1) and carbon monoxide lung diffusing capacity (DLCO) (regardless 
of the FEV1 values). 
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In fact, these parameters are still crucial in the effort of quantifying the post- 
surgery mortality risk and the perioperative risk of complications. 
Despite some limitations highlighted by several studies published by  the end of 
the 90s, the preoperative FEV1 and DLCO are still pivotal parameters used in 
clinical practice to define the surgical risk in lung cancer patients and, in some 
cases, to exclude patients from a potentially curative surgical therapy (14-18). 
As well as for the quantification of the operative risk, FEV1 and DLCO have been 
used in several studies to determine the longitudinal impact of major pulmonary 
resections for lung cancer on respiratory function (19). 
These studies showed that pulmonary resections led to different levels of 
functional impairment depending on the extent of resection and variable on the 
time-point of postoperative evaluation. Considering in particular the open 
standard lobectomy, this procedure results in reduction of respiratory function in 
the early postoperative period with a subsequent significant recovery after 3-6 
months after the operation (19,20). 
I.3 Role of cardiopulmonary exercise test 
Over the past 10 years, the cardiopulmonary exercise tests have taken a central 
role to overcome the limitations of the above mentioned surgical risk assessment 
parameters in patients undergoing lung resection (21,22). 
In particular the high-tech maximal cardiopulmonary exercise test (CPET) is 
increasingly used to assess the aerobic capacity  of a candidate for pulmonary 
resection (23-26). The rationale is that the patients with a preoperative impaired 
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aerobic reserve could experience a greater difficulty dealing with the multiple 
pathophysiologic changes that accompany major surgical procedures. In fact, 
during the normal postoperative period a rise in oxygen consumption of a 
variable extent is expected and the onset of a complication may further increase 
the oxygen requirements beyond that which the patient can provide. This 
postoperative situation inevitably induces an oxygen debt, which, remaining 
critically high over specified periods of time, could lead to a multiorgan failure. 
Increasing evidence has supported the use of CPET (especially the VO2max 
value, that can be directly  measured by this test) for the quantification of 
operative risk in lung surgery, in particular for those patients with marginal 
respiratory functions. So, the ergometric evaluation has acquired such 
importance that the ERS/ESTS task force recommended a more liberal use of 
cardiopulmonary exercise test, which became crucial in guiding the preoperative 
functional assessment strategy (12). 
I.4 Role of quality of life assessment 
Especially from the patient’s perspective, the risk of an impaired quality of life 
(QOL) after surgery is an important consideration when deciding whether to 
proceed with surgery. Some patients may be ready to face the risk of immediate 
perioperative complications (even death) but are not prepared to accept 
significant postoperative debility. 
As a consequence, the potential benefit (survival) of an operation should be 
weighed not only against morbidity and mortality, but also against residual health-
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related QOL measures. Therefore a more comprehensive patient counseling 
should also include reliable information about the anticipated residual QOL. 
Although the need exists for a more comprehensive understanding of the effects 
of thoracic surgery  on patients’ functional and QOL outcomes, at present very 
few studies have addressed this subject. 
Some recently published papers demonstrated that candidates for lung resection 
with lung cancer had a worse preoperative quality of life compared with the 
general population (27,28). Moreover it has been verified that the QOL measures 
had poor correlation with those parameters traditionally used to assess the 
postoperative functional loss (such as FEV1, DLCO, VO2max), in patients 
submitted to open major pulmonary resection for lung cancer (29). Therefore, the 
functional variables cannot substitute for specific evaluation instruments apt at 
measuring the subjectively perceived QOL. At the same time, scarce evidence 
analyzed the longitudinal changes and the mechanisms of recovery of QOL 
patients submitted to major lung resection for neoplasm. 
Unfortunately, both in the preoperative risk stratification and in the evaluation of 
the postoperative impact of lung surgery, the vast majority of the published works 
takes into account pulmonary  resections performed with the traditional technique 
(standard thoracotomic lobectomy). Therefore, there is a lack of knowledge about 
the impact of the vats lobectomy on patients functional and mental recovery after 
the operation and on the surgical risk specific for this approach. 
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II. PROJECT DESCRIPTION AND METHODS
This project was aimed at verifying the long-term impact of the VATS lobectomy 
technique on physical and mental status of patients undergoing lung resection for 
lung cancer. 
For this purpose, we identified the following endpoints of the study: 
PRIMARY ENDPOINTS
# to verify  the physical status variation after the VATS lobectomy, comparing the 
preoperative and the 3 months postoperative patients physical examinations 
(PFTs, DLCO, CPET) 
# to verify  the mental status variation after the VATS lobectomy, comparing the 
preoperative and the 3 months postoperative QoL questionnaire measurement 
(EORTC C30) 
SECONDARY ENDPOINT
# to verify  the differences between the VATS lobectomy and the standard open 
lobectomy in terms of physical status variation, using a propensity score 
matching analysis
We prospectively enrolled in the present study the surgical patients referred to 
the Unit of Thoracic Surgery - AOU Ospedali Riuniti of Ancona since June 2012 
to June 2015 and treated by the VATS lobectomy approach. 
The specific inclusion and exclusion criteria used for the prospective patients 
enrollment are shown below:
Inclusion criteria: 
9
1. All patients (both sex and adults) candidates for elective surgical 
treatment (lobectomy) for primary or secondary lung cancer 
2. Informed consent obtained
Exclusion criteria: 
! ! 1. Previous thoracic operations
! ! 2. Candidates to pneumonectomy or resection less than lobectomy 
! ! 3. Cardiological contraindications to CPET 
4. Incontrollable hypertension 
5. Incontrollable diabetes 
6. Inability to perform CPET (musculoskeletal, cerebrovascular, 
neurologic, psychiatric, severe peripheral vascular diseases) 
 
The enrollment of each patient was decided during the weekly clinical meeting for 
the discussion of new lung resection candidates.
Considering the secondary endpoint (functional comparison between open and 
VATS lobectomy patients 3 months after the operation), we queried our 
institutional prospectively  maintained database in order to retrospectively obtain 
data about patients treated by the open lobectomy approach since January  2010 
to May 2012. These data were used for the comparative analysis between open 
and VATS lobectomy patients. We adopted the following query as retrospective 
inclusion criteria: patients (both sex and adults) submitted to elective open 
pulmonary lobectomy for primary and secondary lung cancer which performed a 
preoperative and postoperative (3 months) functional evaluation.
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Only those patients with a complete preoperative and postoperative functional 
evaluation (FEV1, DLCO and VO2max concurrently available) within both VATS 
and open lobectomy groups were selected for the matched analysis.
Fifteen days before and three months after the operation the patients were 
evaluated to assess their physical status (PFTS, DLCO measurement, CPET) as 
well as their quality of life perception (quality of life questionnaire EORTC C30). 
The parameters used to verify the variation of the patients’ physical status after 
the VATS lobectomy were: FEV1%, DLCO% and VO2max. 
Pulmonary function tests were performed according to the American Thoracic 
Society criteria. The DLCO was measured by the single-breath method. Results 
of spirometry and DLCO were collected after bronchodilator administration and 
were expressed as percentage of predicted for age, sex, and height according to 
the European Community for Steel and Coal prediction equations (30).
Chronic obstructive pulmonary disease (COPD) was defined according to the 
Global Initiative for Chronic Obstructive Lung Disease (GOLD) criteria (FEV/
forced vital capacity [FVC] < 0.7) (31). 
For the maximal oxygen consumption measurement, a symptom-limited CPET 
was systematically performed in all patients on an electronically braked cycle 
ergometer, using a ramp-pattern increase in work rate to reach an exercise test 
duration between 8 and 12 minutes. The exercise test was stopped when 1 or 
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more of the following criteria were present: fatigue, dyspnea, excessive systemic 
blood pressure increase (ie, > 230/130 mm Hg), a greater than 2-mm ST 
depression in at least 2 adjacent leads, or angina). The VO2max was the 
average VO2 during the last 15 seconds of exercise.
In order to measure the patients’ health related quality  of life and its variation 
after the VATS lobectomy, we used the European Organization for Research and 
Treatment of Cancer Quality of Life Core Questionnaire (EORTC QLQ-C30) (32). 
Answering the questions reported within the EORTC QLQ-C30 module, it was 
possible to obtain several scales able to measure different aspects of the 
perceived quality of life (Tab.1). 
For the purpose of the present study we recorded and analyzed the variation of 
the preoperative and postoperative Global Health Status and the variation of the 
five Functional Scales (i.e. Physical Functioning, Role Functioning, Emotional 
Functioning, Cognitive Functioning and Social Functioning).
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Tab.1. Psychological parameters measured by the EORTC C30 module 
Definition
Global health status
QL2
Functional scales
PF2
RF2
EF
CF
SF
Symptom scales
FA
NV
PA
DY
SL
AP
CO
DI
FI
General Quality of Life
Physical Functioning
Role Functioning
Emotional Functioning
Cognitive Functioning
Social Functioning
Fatigue
Nausea and Vomiting
Pain
Dyspnoea
Insomnia
Appetite Loss
Constipation
Diarrhea
Financial Diﬃculties
The definition of the patient surgical risk and the consequent selection of the 
optimal surgical therapy  were obtained taking into account the following 
preoperative evaluation protocol: 
ERS/ESTS clinical guidelines on fitness for radical therapy in lung cancer 
patients (surgery and chemo-radiotherapy) (12). 
During the study period, the VATS lobectomy was performed using both the 
uniportal or biportal technique. In case of a minimally invasive videoassisted 
biportal approach, a single port incision for the camera and a 5 cm incision (utility 
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incision) for the passage and manipulation of instruments were used. In case of 
the uniportal approach a unique 4-5 cm incision was performed at the level of the 
fifth intercostal space in the anterior axillary line. Through this single incision all 
the operative instruments as well as the 5-mm thoracoscope were inserted.
The ribs were not resected or spread. 
Mediastinal systematic nodal dissection or at least nodal sampling was 
performed for all cases. 
The pulmonary veins, pulmonary artery (PA) branches, and bronchus were 
divided individually with endoscopic staplers. 
All operating steps were performed through direct observation on the monitor and 
not by direct examination through the utility incision.
The open traditional approach was performed through a muscle sparing and 
intercostal nerve sparing lateral thoracotomy, in order to avoid nerve crushing 
during the operation. The ribs were spread using a Finocchieto retractor and 
closed at the end of the operation by two single non-absorbable stitches, 
preserving the nerves of the intercostal spaces above and below the 
thoracotomy.
After the surgical procedure, both in the VATS and in the open approach, a single 
chest tube was placed to drain the pleural cavity. In case of the uniportal VATS, 
the tube was inserted through the operative incision.
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All the patients were managed using intraoperative and postoperative 
standardized protocols, aimed at a fast-tracking the patients after major lung 
resection. 
The postoperative complications were classified adopting the definitions 
proposed by the ESTS Database Committee (33,34). According to these 
definitions the “major cardiopulmonary morbidity” included any of the followings: 
- pulmonary complications: pneumonia, atelectasis requiring bronchoscopy, 
adult respiratory  distress syndrome, mechanical ventilation longer than 24 
h, pulmonary edema, pulmonary embolism;
- cardiac complications: myocardial ischemia, cardiac failure, arrhythmia, 
stroke, acute renal insufficiency.
Postoperative complications and mortality were considered as those occurring 
within 30 days postoperatively, or over a longer period if the patient was still in 
the hospital.
An electronic prospective database was designed for the collection and 
management of patients’ clinical data. During the study period the data quality of 
the registry was routinely checked using task independent quality metrics.
At the end of the data collection phase, the base of data was revised using 
standardized and registered procedures of data cleaning.
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The present study project has been developed taking into account the ethical 
principles of Good Clinical Practice.
At the same time the researchers followed the ethical rules for the medical 
research involving humans, as stated in the Declaration of Helsinki by the World 
Medical Association.
The present study was approved by the local Institutional Review Board.
II.1 STATISTICAL ANALYSIS
Normal distribution of numerical variables was assessed by the Shapiro Wilk 
normality  test. Numerical variables with normal distribution were compared by the 
unpaired Student’s t-test and those without normal distribution by the Mann–
Whitney test. Categorical variables were compared by the chi-square test or 
Fisher’s exact test as appropriate. 
In order to compare the postoperative (three months) physical and mental 
variation between open lobectomy and VATS lobectomy patients, we matched 
them according to their baseline characteristics.  The conditional probability  to be 
managed by the VATS technique (propensity score) was estimated by logistic 
regression analysis incorporating the following variables: age, gender, body mass 
index, smoking history-pack-years, Charlson’s Comorbidity  Index, Eastern 
Cooperative Oncology Group score, Zubrod score,  forced expiratory volume in 
one second to forced vital capacity ratio (FEV1/FVC ratio), presence of coronary 
artery  disease, hypertension, history  of arrhythmia, presence of arterial vascular 
disease, primary or secondary lung cancer diagnosis, pT status, pN status.  
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All variables were at least 95% complete and sporadic missing values were 
imputed by taking the most frequent response category  or averaging non-missing 
values for continuous variables. 
The VATS lobectomy patients were matched to the open lobectomy counterparts 
by choosing the patient with the nearest propensity score (35). 
The procedure yielded 83 well-matched pairs of open and VATS patients. The 
categoric variables of the two groups of propensity score matched patients were 
compared by the chi-square test or Fisher’s exact test as appropriate. Numeric 
variables were compared using the unpaired t-test (normal distribution) or the 
Mann–Whitney test (non-normal distribution). 
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III. RESULTS
III.1 General population
From January 2010 through June 2015, 319 patients submitted to pulmonary 
lobectomy for primary or secondary lung cancer at our unit matched the inclusion 
criteria and were enrolled in the present study. 
The mean age was 67 years and 72.4 % of the patients were male.
Most of the operations were performed for treating primary lung cancer (90.3%) 
and 45.5% of patients (142) were operated on using the VATS lobectomy 
approach. 
From the functional point of view, the patients had good spirometric parameters 
(mean FEV1: 86.7%), but a suboptimal lung diffusion capacity (mean DLCO: 
78.6%). On average, the patients experienced VO2max values over the 
threshold to perform safe major lung resections.
This group of lung cancer surgical patients had a perceived global health status 
lower than the general population of the same mean age (QL2: 71.5) (36).
Table 2 summarises several baseline characteristics of our patents. 
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Tab 2. General characteristics of the entire population
VARIABLE nbr.val mean std.dev
age
bmi
fev1
fev1/fvc
dlco
vo2max (ml/kg/min)
pack-years
QL2 pre
PF2 pre
RF2 pre
EF pre
CF pre
SF pre
open/vats
sex (m/f)
asa (low/high)
ecog (low/high)
cci (low/high)
res. Estesa
chest wall
morphology (prim/sec)
pT (low/high)
pN (low/high)
319 67,3 10,6
319 26,2 4,4
319 86,7 19,1
319 0,7 0,1
319 78,6 19,7
254 16,4 3,7
319 40,1 38,0
149 71,6 18,6
150 90,2 12,5
148 92,4 13,7
149 80,1 17,0
149 91,4 13,2
147 93,0 13,6
nbr.val percent number
319 55,5 / 44,5 177 / 142
319 72,4 / 27,6 231 / 88
319 61,7 / 38,3 197 / 122
319 63 / 37 201 / 118
319 57 / 43 182 / 137
319 5,3 17
319 0,9 3
319 90,3 / 9,7 288 / 31
319 53,6 / 46,4 171 / 148
319 94,7 / 5,3 302 / 17
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III.2 VATS lobectomy patients
Table 3 shows the characteristics of those patients treated by the VATS 
lobectomy approach. Even in this case the preoperative functional status of the 
patients was of high level (FEV1: 90.4%, VO2max: 16.6 ml/kg/min) with the 
exception of the DLCO. Again the patients reported an impaired perceived global 
quality  of life (QL2: 72.7). A great proportion of the patients was affected by 
cardiovascular diseases (hypertension 52.8%, coronary artery disease 39.4% 
arrhythmia: 15.5%, cardiac failure: 5.6%, cerebrovascular disease: 5.6%, 
peripheral arterial vascular disease: 7%), and about 40% of the patients had a 
Charlson’s Comorbidity index >2.
The mean operation time for performing the VATS lobectomy procedure was 197 
min. During the postoperative period the patients experienced a mean air leak 
duration of about 2 days and the mean hospital stay was 5.4 days. 
The rate of major cardiopulmonary complications was 9.1%, with a great 
proportion of pulmonary adverse events (5.6%). 
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Tab. 3. Baseline, surgical and postoperative characteristics of the VATS 
lobectomy patients’ group 
baseline characteristics
VARIABLE
age (years)
bmi
fev1
fev1/fvc
dlco
vo2max (ml/kg/min)
pack-years
QL2 pre
PF2 pre
RF2 pre
EF pre
CF pre
SF pre
sex (M)
asa (low)
ecog (low)
cci (low)
IA (yes)
CAD (yes)
aritmia.pre (yes)
cardiac.fail.pre (yes)
cerebrovasc.pre (yes)
vasculop.pre (yes)
renal.pre (yes)
liver.pre (yes)
surgical and postop characteristics
VARIABLE
operation time (min)
air-leak (days)
pleural eﬀusion (ml)
hospital stay (days)
extended resection (yes)
chest wall (yes)
morphology (primary)
pT (low)
pN (low)
compl.tot (yes)
compl.cardiopulm (yes)
compl.cardiac (yes)
compl.pulm (yes)
nbr.val mean std.dev
142 68,5 10,2
142 26,1 4,4
142 90,4 20,1
142 0,7 0,1
142 76,6 19,0
105 16,6 3,8
142 33,5 34,3
111 72,7 19,1
112 89,5 13,5
110 92,6 14,0
111 79,5 17,1
111 91,7 13,1
110 93,0 14,0
nbr.val percent number
142 62,7 89
142 95,1 135
142 68,3 97
142 59,1 84
142 52,8 75
142 39,4 56
142 15,5 22
142 5,6 8
142 5,6 8
142 7 10
142 12 17
142 14,1 20
nbr.val mean std.dev
142 197,4 50,4
142 1,9 4,8
142 459,6 231,4
142 5,5 3,8
nbr.val percent number
142 2,1 3
142 0,7 1
142 90,8 129
142 64,1 91
142 92,2 131
142 20,4 29
142 9,1 13
142 3,5 5
142 5,6 8
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Considering the variation of the physical indicators three months after the 
operation, we found a general reduction in comparison to the preoperative 
values. In particular the DLCO had a negative variation of 12.4%. (Tab. 4).
A similar negative trend was found for the psychological indicators, even though 
the only parameter with a significative worsening was the perceived physical 
functioning (reduction: 6.2%, p <0.001).
Tab. 4. Physical and psychological variation of the VATS patients 3 months after 
the operation.
VARIABLE preop       
(mean, SD)
postop     
(mean, SD)
var % p.value nbr.val
fev1
dlco
vo2max
QL2
PF2
RF2
EF
CF
SF
90,4 (20,1) 82,9 (18,6) -8,3 <0,001 142
76,6 (18,9) 67,1 (17,3) -12,4 <0,001 142
16,6 (3,7) 15,5 (3,5) -6,6 <0,001 84
76,7 (19,1) 72.8 (18,8) -5,1 0,878 94
89,5 (13,5) 83,9 (13,5) -6,2 <0,001 94
92,6 (14,1) 88,3 (17,6) -4,6 0,115 94
79,5 (17,1) 80,5 (17,2) 1,2 0,3872 94
91,7 (13,1) 88,7 (14) -3,3 0,2115 94
93 (14) 91,5 (15,1) -1,6 0,4678 94
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The figure 1 shows the mean physical and psychological values highlighting their 
lower level in the postoperative period, with the exception of the variation 
registered for the emotional functioning indicator (increase: 1.2% p: 0.39)
Fig. 1. Comparison of the preoperative and postoperative physical and 
psychological indicators and their variation
-15
8
31
54
77
100
fev1* dlco* vo2max* QL2 PF2* RF2 EF CF SF
preop       postop var %
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The tables 5, 6, 7, and 8 show the variations of the physical and psychological 
indicators in particular risk groups of patients (elderly, COPD patients, patients 
with cardiovascular disease and complicated patients) within the VATS lobectomy 
population and the comparison with the variations for the correspondent 
counterparts (young, non-COPD patients, patients without cardiovascular 
disease and non-complicated patients). 
For all the considered subgroups we observed a constant reduction of the 
physical indicators. The negative trend was again mostly evident for the DLCO 
reduction.
In the comparison between young and elderly patients the percentage of the 
FEV1 variation ( (FEV1pre - FEV1post) / FEV1pre) was higher for the young 
ones (FEV1 variation young: -10.5% vs FEV1 variation elderly: -4.6%, p value: 
0.02) (Tab.5).
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Tab. 5. Physical and psychological variation for young and elderly  patients within 
the VATS group
young (61) elderly (81) variation comparison
VARIABLE
fev1
dlco
vo2max
QL2
PF2
RF2
EF
CF
SF
preop postop p.value preop postop p.value young elderly p.value
89,7
(20,4)
78,8
(16,1)
< 0.001 91
(19,9)
86
(19,8)
0,001 -10,5 -4,6 0,02
78,5
(17)
68
(15,9)
< 0.001 75,1
(20,2)
75,1
(18,4)
< 0.001 -12,2 -10 0,4
17,4
(4,4)
16,1
(4,4)
0,06 16,1
(3,1)
15,2
(2,7)
0,003 -7,2 -6,7 0,9
70,5
(17,1)
70,4
(18)
0,6 74,4
(20,6)
74,6
(19,4)
0,9 3,2 7,7 0,5
90,8
(10,8)
85,1
(12,2)
0,001 88,3
(15,3)
82,9
(14,5)
0,002 -5,2 -3,7 0,7
92,6
(13,5)
88,4
(16,5)
0,09 92,5
(14,5)
88,2
(18,7)
0,5 -3,2 2,7 0,3
77,3
(17,4)
79,5
(17,4)
0,3 81,3
(16,7)
81,5
(17)
0,7 5,8 4,2 0,8
94,3
(10,4)
90,8
(11,4)
0,4 89,6
(14,6)
87
15,7
0,3 0,1 -0,4 0,9
91,1
(15,6)
87,8
(18,7)
0,3 94,5
(12,4)
94,6
10,6
0,9 0,6 0,4 0,5
Results are expressed as mean and standard deviation (in brackets) when indicated
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COPD and non-COPD patients experienced a similar trend of variation for all the 
analyzed parameters.
Tab. 6. Physical and psychological variation for COPD and non-COPD patients 
within the VATS group
COPD (68) non-COPD (74) variation comparison
VARIABLE
fev1
dlco
vo2max
QL2
PF2
RF2
EF
CF
SF
preop postop p.value preop postop p.value COPD nonCOPD p.value
83,9
(18,5)
79,3
(18,6)
0,002 96,4
(19,8)
86
(18)
<0.001 -4,7 -9,4 0,07
72,1
(19,9)
63,7
(18,4)
<0.001 80,7
(17,2)
70
(15,8)
<0.001 -11 -11 0,9
16,1
(3,52)
16
(3,1)
0,1 17,2
(3,93)
15
(3,8)
0,002 -3,4 -10,0 0,1
72,3
(20,2)
74,7
(17,8)
0,6 73,0
(18,3)
71
(19,6)
0,4 9,8 1,8 0,3
88,7
(15,7)
84,5
(13,9)
0,007 90,1
(11,3)
83,4
(13,2)
<0.001 -2,5 -6,0 0,3
92,8
(14)
91,2
(15,0)
0,8 92
(14,3)
85,6
(20)
0,08 3,1 -2,8 0,3
79,0
(16,9)
82,9
(16,0)
0,3 79,9
(17,3)
78,3
(18)
0,8 7,4 2,7 0,4
90
(14,8)
89,5
(14,1)
0,9 93,5
(11,2)
87,9
(14)
0,03 3,0 -2,9 0,2
94,1
(14,8)
93,8
(12,3)
1,0 92,1
(13,3)
89,5
(17,1)
0,3 5,00 -0,90 0,3
Results are expressed as mean and standard deviation (in brackets) when indicated
Patients with cardiovascular disease had a postoperative negative variation of 
the VO2max index significantly higher than their counterparts (VO2max variation 
pts with cardiovascular disease: -10.7% vs VO2max variation pts without 
cardiovascular disease: -2.2%, p value: 0.04) (Tab. 7).
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Tab. 7. Physical and psychological variation for cardiovascular disease and non-
cardiovascular disease patients within the VATS group
cardiovascular disease 
(86)
non-cardiovascular 
disease(56)
variation comparison
VARIABLE
fev1
dlco
vo2max
QL2
PF2
RF2
EF
CF
SF
preop postop p.value preop postop p.value cardiov non cardiov p.value
90,6
(20,7)
83,1
(18,4)
<0,001 90,3
(19)
82,6
(19)
<0,001 -6,8 -7,5 0,8
76,3
(20,1)
67
(17)
<0,001 77,1
(17,1)
67,3
(17,9)
<0,001 -10,7 -11,3 0,9
16,2
(3,2)
14,6
(3,2)
<0,001 17,3
(4,3)
16,6
(3,5)
0,3 -10,7 -2,2 0,05
73,7
(19,2)
72,3
(18)
0,7 71,4
(19,1)
73,4
(19,6)
0,9 4,4 7,1 0,7
86,6
(15,6)
82
(14,3)
0,02 93,3
(8,8)
86,3
(11,9)
<0,001 -1,9 -7,7 0,08
90,3
(16,4)
88
(17,4)
0,6 95,5
(9,6)
89,1
(18,2)
0,07 3,7 -4,8 0,2
79,8
(16,8)
80
(17,4)
0,4 79,2
(17,5)
81,6
(16,9)
0,7 3,8 6,3 0,7
89,4
(13,2)
86,7
(13,7)
0,1 94,8
(12,5)
91,8
(14,1)
0,7 -1,5 1,5 0,5
91,9
(14,4)
92
(12,7)
0,6 94,4
(13,5)
90,5
(18,3)
0,1 5,4 -2,7 0,2
Results are expressed as mean and standard deviation (in brackets) when indicated
The complicated patients reported a greater reduction of the postoperative 
physical functioning scale in comparison to the non-complicated ones (PF2 
variation complicated: -14.9% vs PF2 variation non-complicated: -3.6% p  value: 
0.04) (Tab.8).
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Tab. 8. Physical and psychological variation for complicated and non-complicated 
patients within the VATS group
complicated (13) non complicated (129) variation comparison
VARIABLE
fev1
dlco
vo2max
QL2
PF2
RF2
EF
CF
SF
preop postop p.value preop postop p.value compl non-compl p.value
87,3
(20,8)
78,7
(11,9)
<0,001 90,8
(20,1)
83,3
(19,1)
<0,001 -6,4 -7,2 0,9
84,5
(24)
68,8
(16,2)
0,01 75,8
(18,3)
67,0
(17,5)
<0,001 -16,5 -10,4 0,2
16
(2,6)
13,6
(3,3)
0,1 16,7
(3,9)
15,7
(3,4)
0,002 -13,6 -6,2 0,4
79,8
(13,5)
80,3
(15,5)
0,8 72,2
(19,4)
72
(19)
0,8 7,1 5,5 0,9
91,4
(7,4)
80,0
(12,4)
0,01 89,3
(13,8)
84,3
(13,6)
<0,001 -14,9 -3,6 0,05
85,7
(24,4)
87,5
(17,6)
1 93,0
(13,1)
88,4
(17,7)
0,09 1,8 -1,4 0,6
84,5
(21,2)
79
(12,6)
0,4 79,2
(16,8)
80,7
(17,6)
0,3 -2,7 5,5 0,4
88,1
(18,5)
83,3
(15,9)
0,4 92
(12,7)
89,3
(13,8)
0,3 -4,3 -1,6 0,4
95,2
(8,1)
91,7
(24,1)
0,6 92,9
(14,3)
91,5
(14)
0,6 -6,2 2,4 0,5
Results are expressed as mean and standard deviation (in brackets) when indicated
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III.3 Open vs VATS comparison
The 85 VATS patients able to entirely complete the preoperative evaluation as 
well as the 3 months follow up were then matched to the open ones (112 
patients), in order to compare the functional loss (FEV1, DLCO and VO2max 
reduction) after VATS vs open lobectomy. 
The table 9 shows the comparison of the baseline, surgical and postoperative 
characteristics of the two groups before the matching procedure. 
Considering the baseline characteristics, the VATS lobectomy patients seemed to 
be older, with higher FEV1 values  (open FEV1: 84.8 vs  VATS FEV1: 93.2) but 
lower DLCO (open DLCO: 82,8 vs  VATS DLCO: 77). The mean VO2max was 
similar in the two groups. 
Moreover there was an higher proportion of patients  with cardiac disease within 
the VATS patients (CAD for VATS: 50.5% vs  for open: 22.3% and cardiac failure 
rate for VATS: 5.6% vs for open 0.6%), but with low ECOG and CCI scores . 
Finally the pack-years indicator was higher for the open patients.
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Tab. 9. Characteristics of open and VATS lobectomy patients before matching
VARIABLE
baseline characteristics
age (years)
bmi
fev1
fev1/fvc
dlco
vo2max
pack-years
sex (M)%
ecog (low)%
cci (low)%
IA (yes)%
CAD (yes)%
aritmia.pre (yes)%
cardiac.fail.pre (yes)%
cerebrovasc.pre (yes)%
vasculop.pre (yes)%
surgical and postoperative 
characteristics
operation time (min)
air-leak (days)
pleural eﬀusion (ml)
hospital stay (days)
extended resection (yes)%
chest wall (yes)%
morphology (primary)%
pT (low)%
pN (low)%
compl.tot (yes)%
compl.cardiopulm (yes)%
compl.cardiac (yes)%
compl.pulm (yes)%
open (112) vats (85) p.value
66,2 (9,8) 69,3 (10,5) 0,04
26,3 (4,1) 25,8 (4,4) 0,47
84,8  (18,2) 93,2 (19,5) 0,003
0,7 (0,1) 0,7 (0,1) 0,76
82,8 (20,7) 77 (19,3) 0,05
16,7 (4) 17 (3,7) 0,42
45,9 (36) 32,3 (30,3) 0,005
81 63,8 0,01
58 73,5 0,04
58,0 61,4 0,7
47,3 48,2 0,9
22,3 50,5 <0,001
10,7 13,2 0,7
0,6 5,6 0,02
6,8 5,6 0,7
8,0 4,8 0,5
182 (64,8) 197,4 (50,4) 0,02
2,1 (5,2) 1,9 (4,7) 0,7
671 (408) 460 (231) <0,001
7,1 (7,4) 5,4 (3,8) 0,01
7,9 2,1 0,04
1,1 1 0,7
89,8 90,8 0,2
45,1 64,1 <0,001
96,6 92,2 0,1
26,5 20,4 0,2
14,7 9,1 0,1
6,8 2,8 0,1
7,9 6,3 0,3
Results are expressed as mean and standard deviation (in brackets) when indicated
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The propensity score yielded 83 well-matched pairs of open and VATS patients.
The table 10 reports the results of the comparison between the open and VATS 
matched patients.
All the variables selected for the matching procedure resulted not different 
between the two groups, with the exception of the rate of patients with CAD, that 
was still grater for the VATS patients group (CAD rate open patients: 28.9% vs 
CAD rate VATS patients: 50.6%, p value: 0.01).
In the postoperative period the VATS patients experienced a lower pleural 
effusion and a shorter hospital stay than their open counterparts  (hospital stay 
open patients: 6.3 days vs hospital stay VATS patients 4.6 days, p value < 
0.001).
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TABLE 10 Characteristics of open and VATS lobectomy patients after matching
VARIABLE
baseline characteristics
age (years)*
bmi*
fev1/fvc*
pack-years*
sex (M)%*
ecog (low)%*
cci (low)%*
IA (yes)%*
CAD (yes)%*
aritmia.pre (yes)%*
cardiac.fail.pre (yes)%
cerebrovasc.pre (yes)%
vasculop.pre (yes)%*
surgical and postoperative 
characteristics
operation time (min)
air-leak (days)
pleural eﬀusion (ml)
hospital stay (days)
extended resection (yes)%
chest wall (yes)%
morphology (primary)%*
pT (low)%*
pN (low)%*
compl.tot (yes)%
compl.cardiopulm (yes)%
compl.cardiac (yes)%
compl.pulm (yes)%
open (83) vats (83) p.value
66,7 (10,2) 69,3 (10,5) 0,1
26,3 (4,2) 25,8 (4,3) 0,5
0,71 (0,1) 0,7 (0,1) 0,6
40,3 (30,1) 32,4 (30,3) 0,09
77,10 63,8 0,09
65,10 73,40 0,3
56,60 61,40 0,6
36,10 48,20 0,1
28,90 50,60 0,01
8,40 13,20 0,4
1,20 9,60 0,06
7,20 6,00 1
7,20 4,80 0,7
189,9 (72,2) 200,9 (53,2) 0,3
2,1 (4,9) 1,1 (3) 0,1
675,8 (329,6) 471,9 (239,2) <0,001
6,3 (3,7) 4,6 (2,4) <0,001
8,4 3,6 0,3
0,0 1 1
94,0 95,2 0,5
42,2 56,6 0,08
94,0 90,4 0,6
22,9 15,7 0,3
16,9 9,6 0,6
8,4 2,4 0,07
8,4 7,2 1
Results are expressed as mean and standard deviation (in brackets) when indicated
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As reported in Tab. 11, even for the matched open and VATS patients, we found 
a decrease of the three months postoperative FEV1, DLCO and VO2max values 
in comparison to the preoperative ones (open patients’ reduction: FEV1 -10%, 
DLCO -11.9%, VO2max -5.5%; VATS patients’ reduction: FEV1 -7.2%, DLCO 
-10.6%, VO2max -6.9%).
The reductions in FEV1, DLCO and VO2max were similar in  the matched open 
patients and VATS patients, with a  Cohen  effect size < 0.2 for all 
the comparisons, indicating negligible differences. 
Tab.11 Comparison of FEV1, DLCO and VO2max variations between open and 
VATS matched patients 
open vats variation comparison
fev1
dlco
vo2max
pre post pre post open vats p.value choen
85,4 76,9 93,1 86,4 -10 -7,2 0,2 0,2
82,6 72,8 77 68,9 -11,9 -10,6 0,7 0,1
17,4 16,4 17 15,8 -5,5 -6,9 0,6 0,1
These results are clearly demonstrated also by the bar charts and the box plots 
of Figure 2, 3 and 4.  The box-plots show similar and consensual variations for 
both groups in all the functional variables. Moreover the bar charts have a similar 
trend of variation in the open and VATS matched patients and the columns are 
almost overlapping for the DLCO variation.
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Fig. 2. FEV1 variation in open and VATS matched patients
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Fig. 3. DLCO variation in open and VATS matched patients
35
Fig. 4. VO2max variation in open and VATS matched patients
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IV. DISCUSSION
The objective of the present study was to evaluate the changes of pulmonary 
function, exercise capacity  and quality  of life after pulmonary lobectomy for lung 
cancer performed through a VATS approach. Moreover we wanted to compare 
the physical changes of the VATS lobectomy patients to the ones registered in 
patients submitted to the traditional open lobectomy. 
This study was conducted on a prospective series of patients operated on a 
single centre and managed preoperative and postoperatively  using standardised 
protocols and pathways of care. Since we adopted (after completing during the 
previous two years the learning curve period) the VATS technique as the first 
choice approach for performing lobectomies in January 2012, we had the 
opportunity to study the functional and psychological impact of this novel 
approach in a three months follow up  program. At the same time we could 
compare the VATS long term functional outcomes to the results obtained with the 
open lobectomies, performed since January 2010 and collected within our 
institutional prospective database. 
At present, this represents the largest series of lung cancer surgical patients 
submitted to a systematic follow up program, where the physical examination 
consisted not only in a pulmonary function test and DLCO assessment but also in 
a direct measurement of the maximal oxygen uptake, using a formal high tech 
cardiopulmonary exercise test.
In order to investigate a stable postoperative physical and psychological 
condition minimising the dropout rate, we chose the 3-month period as evaluation 
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time. In fact, the drop out rates could affect the results in follow-up studies as the 
patients who did not present at follow-up should presumably be considered the 
patients with worse conditions. This could falsely improve the results for a 
selection bias, elsewhere indicated as “cream-skimming” effect (37). Indeed, 26% 
of patients evaluated at 3 month dropped out for several reasons (recurrence, 
adjuvant chemotherapy, onset of further diseases, refusal to show at follow-up). 
Focusing on the physical indicators variation three months after the VATS 
lobectomy operation, we found a reduction for each of them. The mean DLCO 
loss from the preoperative values was remarkable (-12.4%) and with potential 
clinical relapses, especially for those patients with a preoperatively impaired lung 
diffusion capacity (i.e. patients with pulmonary  hypertension, interstitial lung 
disease, COPD) . This seems in line with the DLCO reduction observed in 
previously published papers, for patients submitted to pulmonary open lobectomy 
(38).   Moreover we registered for the FEV1 and the DLCO an higher drop at 
three months in comparison to the one observed for the VO2max. This result 
corroborates the findings of other studies on patients submitted to open major 
lung resection, which argued that a more complete recovery of exercise 
tolerance, compared to the airflow and gas exchange capacities, is  presumably 
due to compensatory mechanisms related to the cardiovascular system and the 
peripheral oxygen extraction capacity (38, 39).
Then we analysed the FEV1, DLCO and VO2max variation three months after 
38
the VATS lobectomy in some subgroups of patients, in order to verify the 
reliability of the results found on the general population.
The sub-analysis revealed a similar reduction of the functional parameters for all 
the groups considered. Nevertheless, we found that younger patients had an 
higher loss of the three months FEV1 than the one registered for the elderly. This 
finding may be explained by the fact that the lung resection in young patients 
implies the loss of more healthy  pulmonary tissue, while the elderly sacrifice an 
higher proportion of emphysematous lung (which contributes less to the 
respiratory  function). On the other hand we didn’t observe a different level of 
FEV1 reduction when we compared the COPD vs non-COPD subgroups of 
patients. 
Moreover we found that patients affected by cardiovascular disease had lower 
VO2max preoperative values than their counterparts. Furthermore, the 
cardiovascular patients experienced an higher reduction of their exercise 
capacity in comparison to the healthier patients.
This trend of postoperative reduction observed in the physical indicators was 
also perceived by the patients. In fact, the EORTC results showed that they 
experienced a relevant worsening of the physical functioning scale.
On the opposite site, the three months global health perception as well as the 
other functional scales evaluated by the EORTC were not different from the 
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preoperative correspondent values. This suggest that, even after a minimally 
invasive major lung resection aimed at curing a neoplastic disease, the patients 
did’t consider this treatment as a crucial step to improve their quality  of life. They 
rather complained about an impairment of their preoperative physical 
performance. Moreover, in the subgroup analysis, we found that the patients 
which experienced postoperative complications perceived a even greater 
reduction of the postoperative physical functioning scale in comparison to the 
non-complicated ones. A similar trend of the perceived quality of life was found in 
other studies, although performed using different questionnaires and examining 
open lobectomy patients (40, 41). 
The propensity score matching procedure gave us the possibility of comparing 
the physical parameters’ variations three months after the operation between two 
homogeneous groups of open and VATS lobectomy patients.
We found a postoperative reduction of FEV1, DLCO and VO2max for both 
groups. Even in this case the rate of reduction was lower for the exercise 
capacity. 
The most interesting results is represented by the consensual variation for all the 
physical parameters both in the open and VATS lobectomy patients. This means 
that the VATS lobectomy approach didn’t offer any functional advantage in a 
three months perspective. The physical performance recovery seemed to reach 
the same level irrespectively  to the surgical approach considering a long term 
follow up, in contrast to the findings reported by studies which analyses the short 
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term recovery of the functional status after VATS lobectomy (42,43).
IV.1 Limitations
A possible limitation of this study is one common to most of the follow-up 
analyses and concerns the patients who dropped out. As these patients could 
have been patients with the worst functional status, their inclusion in the analysis 
could have perhaps changed the results, and this should be taken into account 
when interpreting the results. 
A certain proportion of our patients received adjuvant chemotherapy. As 
chemotherapy has been proven to impair gas exchange, the inclusion of these 
patients could have influenced the results. However, only  17 patients studied at 3 
months were submitted to adjuvant chemotherapy. We decided to include theme 
after a preliminary  analysis that did not show differences in PFT results and 
VO2max at 3 months compared to the other patients 
We couldn’t compare the three months postoperative mental status of open vs 
VATS lobectomy patients as we didn’t collect the EORTC C30 results of the open 
patients within our institutional prospective database. 
IV.2 Conclusions
The VATS lobectomy influences a reduction of the preoperative functional status 
three months after the operation.
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The reduction of FEV1 and DLCO is partially covered by compensatory 
mechanisms and the global exercise capacity is almost completely  restored three 
months postoperatively.
The VATS lobectomy doesn’t affect the postoperative perceived global quality of 
life. Nevertheless the patients, even after a minimally  invasive approach, felt a 
worsening of their physical functioning.
In a three months perspective, the VATS lobectomy doesn’t offer any advantage 
in terms of FEV1, DLCO and exercise capacity  recovery in comparison to the 
muscle-sparing thoracotomy approach.
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